Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers

Clinical and Vaccine Immunology

Volumn 18, Issue 7, 2011, Pages 1176-1182

  Ringshausen, Felix C ^a   Nienhaus, Albert ^a   Costa, José Torres ^b   Knoop, Heiko ^c   Schlösser, Stephan ^c   Schultze Werninghaus, Gerhard ^c   Rohde, Gernot ^d  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b University of Porto   (Portugal)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RESPONSE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; IMMUNOCOMPROMISED PATIENT; INTERFERON GAMMA RELEASE ASSAY; MALE; MYCOBACTERIUM TUBERCULOSIS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; RISK FACTOR; SCREENING; TUBERCULIN TEST; TUBERCULOSIS;

GERMANY; HEALTH PERSONNEL; HUMANS; INTERFERON-GAMMA; MASS SCREENING; MYCOBACTERIUM TUBERCULOSIS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; TUBERCULOSIS;

EID: 79960148323     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05058-11     Document Type: Article

References (37)

1. Barnett, A. G., J. C. van der Pols, and A. J. Dobson. 2005. Regression to the mean: what it is and how to deal with it. Int. J. Epidemiol. 34:215-220.
2. Belknap, R., et al. 2009. Diagnosis of latent tuberculosis infection in U.S. health care workers: reproducibility, repeatability and 6 month follow-up with interferon-gamma release assays (IGRAs). Am. J. Respir. Crit. Care Med. 179:A4101.
3. Cellestis. 2007. QuantiFERON® -TB Gold In-Tube package insert. Cellestis, Melbourne, Australia. http://www.cellestis.com/IRM/Company/ShowPage. aspx?CPID=1255.
4. Centers for Disease Control and Prevention. 2005. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm. Rep. 54(RR-17):1-141.
5. Chee, C. B., et al. 2009. Use of a T cell interferon-gamma release assay to evaluate tuberculosis risk in newly qualified physicians in Singapore healthcare institutions. Infect. Control Hosp. Epidemiol. 30:870-875.
6. Detjen, A. K., et al. 2009. Short-term reproducibility of a commercial interferon gamma release assay. Clin. Vaccine Immunol. 16:1170-1175.
7. Diel, R., et al. 2007. Recommendations for background studies in tuberculosis. Pneumologie 61:440-455.
8. Diel, R., et al. 2011. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur. Respir. J. 37:88-99.
9. Diel, R., R. Loddenkemper, and A. Nienhaus. 2010. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 137:952-968.
10. Diggle, P. J. 1988. An approach to the analysis of repeated measurements. Biometrics 44:959-971.
11. European Centre for Disease Prevention and Control. 2011. Use of interferon-gamma release assays in support of TB diagnosis. European Centre for Disease Prevention and Control, Stockholm, Sweden.
12. Farhat, M., C. Greenaway, M. Pai, and D. Menzies. 2006. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int. J. Tuberc. Lung Dis. 10:1192-1204.
13. Lee, K., et al. 2009. Annual incidence of latent tuberculosis infection among newly employed nurses at a tertiary care university hospital. Infect. Control Hosp. Epidemiol. 30:1218-1222.
14. Mack, U., et al. 2009. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur. Respir. J. 33:956-973.
15. Mazurek, G. H., et al. 2005. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm. Rep. 54:49-55.
16. Mazurek, M., et al. 2010. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm. Rep. 59:1-25.
17. Menzies, D. 1999. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am. J. Respir. Crit. Care Med. 159:15-21.
18. Menzies, D., R. Joshi, and M. Pai. 2007. Risk of tuberculosis infection and disease associated with work in health care settings. Int. J. Tuberc. Lung Dis. 11:593-605.
19. Oxford Immunotec. 2009. T-SPOT.TB package insert (PI-TB8-IVD-UK-V5). Oxford Immunotec, Abingdon, United Kingdom. http://www.oxfordimmunotec.com/8-UK.
20. Pai, M., et al. 2006. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am. J. Respir. Crit. Care Med. 174:349-355.
21. Pai, M., et al. 2009. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int. J. Tuberc. Lung Dis. 13:84-92.
22. Pai, M., and R. O'Brien. 2007. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med. 4:e208.
23. Pai, M., A. Zwerling, and D. Menzies. 2008. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 149:177-184.
24. Perry, S., et al. 2008. Reproducibility of QuantiFERON-TB gold in-tube assay. Clin. Vaccine Immunol. 15:425-432.
25. Pollock, N. R., et al. 2008. Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution? Infect. Control Hosp. Epidemiol. 29:878-886.
26. Ringshausen, F. C., et al. 2010. Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers. BMC Infect. Dis. 10:220.
27. Ringshausen, F. C., et al. 2009. In-hospital contact investigation among health care workers after exposure to smear-negative tuberculosis. J. Occup. Med. Toxicol. 4:11.
28. Sachs, L. 2003. Angewandte statistik: anwendung statistischer methoden, 11th ed. Springer, Berlin, Germany.
29. Schablon, A., et al. 2010. Serial testing with an interferon-gamma release assay in German healthcare workers. GMS Krankenhhyg. Interdiszip. 5:Doc05.
30. Seidler, A., A. Nienhaus, and R. Diel. 2005. Review of epidemiological studies on the occupational risk of tuberculosis in low-incidence areas. Respiration 72:431-446.
31. Torres Costa, J., R. Silva, R. Sa, M. J. Cardoso, and A. Nienhaus. 2011. Serial testing with the interferon-gamma release assay in Portuguese healthcare workers. Int. Arch. Occup. Environ. Health 84:461-469.
32. van Zyl-Smit, R. N., et al. 2009. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am. J. Respir. Crit. Care Med. 180:49-58.
33. van Zyl-Smit, R. N., A. Zwerling, K. Dheda, and M. Pai. 2009. Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One 4:e8517.
34. Veerapathran, A., et al. 2008. T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One 3:e1850.
35. World Health Organization. 2009. WHO policy on TB infection control in health-care facilities, congregate settings and households. WHO, Geneva, Switzerland.
36. Yoshiyama, T., N. Harada, K. Higuchi, Y. Nakajima, and H. Ogata. 2009. Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-gamma assays. Epidemiol. Infect. 137:1691-1698.
37. Zwerling, A., S. van den Hof, J. Scholten, F. Cobelens, D. Menzies, and M. Pai. 12 January 2011, posting date. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax doi:10.1136/thx.2010.143180.